Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAkebia Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Akebia Therapeutics, Inc.

$0.88Close · Oct 6, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $49.13M. Net result −$8.91M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $49.13M. Running result $49.13M. Revenue: $49.13M.
  • Cost of revenue: −$10.42M. Running result $38.7M.
  • Gross profit: $38.7M. Running result $38.7M.
  • Research and development: −$14.06M. Running result $24.65M.
  • Selling, general and administrative: −$28.17M. Running result −$3.53M.
  • License: −$855K. Running result −$4.38M.
  • Restructuring: −$1.95M. Running result −$6.33M.
  • Operating income: −$6.33M. Running result −$6.33M.
  • Other expense: −$2.51M. Running result −$8.84M.
  • Pre-tax loss: −$8.84M. Running result −$8.84M.
  • Income tax expense: −$70K. Running result −$8.91M.
  • Net loss: −$8.91M. Running result −$8.91M.